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Introduction
A challenging goal in synthetic chemistry is the synthesis of complex products from
simple starting materials by using one-step processes such as domino reactions.1–16 A
domino reaction was defined by Tietze in 1993 as a reaction involving two or more
bond-forming transformations, occurring under strictly the same reaction conditions
without adding additional reagents and catalysts.17–20 These economic processes avoid
costly protecting groups and time-consuming purification procedures after each step. In
the last two decades, an impressive number of these powerful reactions have been
developed, allowing the construction of very complex molecules in single steps from
simple materials often with very high stereocontrol and yields. In most cases, remark-
able enantioselectivities have been reported in reactions promoted by either chiral metal
catalysts or organocatalysts. Especially, the considerable impact of the advent of asym-
metric transition-metal catalysis has allowed the immense development of many highly
efficient enantioselective metal-catalyzed domino reactions. The wide variety of these
processes well reflects the variety of metals employed to promote them. This review
collects for the first time the total syntheses of natural and biologically important prod-
ucts employing an enantioselective metal-catalyzed domino reaction as a key step, cov-
ering the years from 1996 to the present.
I. Syntheses Based on Palladium-Catalyzed Domino Reactions
1. Heck-Initiated Domino Reactions as Key Steps
Many syntheses of natural and bioactive products include as key steps asymmetric domino
processes21–27 initiated by a Heck reaction.28–30 As an early example, the first total synthe-
sis of the naturally occurring pentacyclic polyketide (þ)-xestoquinone was developed by
Keay et al., in 1996.31 This compound exhibits important biological activities, such as anti-
malarial, antiproliferative and cardiotonic properties. The key step of this unprecedented
synthesis was an asymmetric palladium-catalyzed domino intramolecular Heck/cyclization
reaction of a functionalized naphthyl triflate. As shown in Scheme 1, the reaction was pro-
moted in toluene at 110C by a combination of Pd2(dba)3 as precatalyst and (S)-BINAP as
chiral ligand in the presence of pentamethylpiperidine (PMP). It afforded the corresponding
key pentacyclic chiral intermediate in good yield (82%); however, the enantioselectivity
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was only moderate (68% ee). The latter was subsequently submitted to a catalytic hydro-
genation on Pd/C followed by oxidation with ceric ammonium nitrate (CAN) to give the
final natural product (þ)-xestoquinone (Scheme 1).
A possible mechanism for the key enantioselective palladium-catalyzed domino
intramolecular Heck/cyclization reaction of the total synthesis of (þ)-xestoquinone
(Scheme 1) is proposed in Scheme 2. It involves a syn-addition insertion of a palladium
complex on the Re-face of the vinyl group to give a pentacyclic palladium intermediate
which is further submitted to a syn-b-elimination to afford the final domino product.
The same year, Shibasaki et al. applied a related methodology to synthesize the
marine natural product (þ)-halenaquinone, exhibiting antibiotic, cardiotonic and protein
tyrosine kinase inhibitory activities.32,33 In this case, the key step of the synthesis was
the enantioselective palladium-catalyzed domino intramolecular Heck/cyclization reac-
tion of a bicyclic triflate performed at 60C in THF as solvent in the presence of a
chiral palladium catalyst generated in situ from Pd(OAc)2 and the chiral ligand (S)-
BINAP mentioned above. It afforded the corresponding domino product in both high
yield (78%) and enantioselectivity (87% ee), as shown in Scheme 3. The latter was fur-
ther converted into the expected (þ)-halenaquinone through fifteen supplementary steps
which are detailed in Scheme 3. First, the domino product was converted into the corre-
sponding alcohol through a two-step sequence. The further transformation of this alco-
hol into the corresponding triflate followed by reaction with a cyanohydrin
triisopropylsilyl ether and then treatment with NaF provided the corresponding
a,b-acetylenic ketone. After protection of the carbonyl function of this compound as an
acetal and that of the ethynyl functionality with a triisopropylsilyl group, the resulting
compound was submitted to benzylic oxidation with DDQ to give the corresponding
ketone. Then, successive treatments with O2 in the presence of tert-BuOK, NaI and
TsOH afforded an a-iodo enol. Subsequently, the latter underwent cyclization in the
presence of Pd2(dba)3 to give the corresponding pentacyclic compound which finally
provided the anticipated (þ)-halenaquinone through successive desilylation by treat-
ment with tetrabutylammonium fluoride (TBAF) and CAN oxidation.
Scheme 1
Later in 2007, Zhu et al. developed another type of enantioselective palladium-cat-
alyzed domino sequence initiated by a Heck reaction to be applied in a total synthesis
of the naturally occurring butyryl-cholinesterase inhibitor (-)-physostigmine, which is
employed for the treatment of glaucoma and Alzheimer’s diseases.34 As shown in
Scheme 4, ortho-iodoanilidines reacted at 120C in DMF as solvent with K4[Fe(CN)6]
through a domino intramolecular Heck/cyanation reaction in the presence of Pd(dba)2
as precatalyst and (S)-DIFLUORPHOS as chiral ligand. This one-pot process led to the
corresponding chiral oxindoles in moderate to good yields (54-78%) and enantioselec-
tivities (61-79% ee). The authors demonstrated that one of these products (R1 ¼ OMe,
R2 ¼ H) could be used as key intermediate in a total synthesis of (-)-physostigmine. As
illustrated in Scheme 4, the reductive cyclization of this domino product with LiAlH4
led to the corresponding hexahydropyrroloindole which was subsequently submitted to
N-methylation under reductive amination conditions to afford esermethole. Then, cleav-
age of the methoxy group of esermethole with HBr led to the corresponding phenol
which was finally submitted to NaH in the presence of N-succinimidyl-N-methylcarba-
mate to give the expected (-)-physostigmine.
In 2015, the same authors also developed a total synthesis of the natural powerful
inhibitor of acetyl-cholinesterase (þ)-esermethole.35 It involved a chiral oxindole/azole
bis-heterocycle as key intermediate which was generated through the first example of
an asymmetric domino Heck/intermolecular arylation reaction. As shown in Scheme 5,
the domino process between oxadiazoles and N-aryl acrylamides was promoted in
acetonitrile at 80C by a chiral palladium catalyst in situ generated from PdCl2(MeCN)2
and a chiral Phox-type ligand in the presence of N,N,N,N-tetramethylguanidine (TMG)
as base. The formed chiral domino bicyclic products bearing a quaternary stereocenter
Scheme 2
were obtained in moderate to excellent yields (55-94%) and high enantioselectivities
(85-99% ee). One of these compounds (R1 ¼ R2 ¼ Me, R3 ¼ H, R4 ¼ Ph) obtained
with 71% yield and 94% ee was converted into (þ)-esermethole through five supple-
mentary steps. The first step dealt with the reduction of this oxindole with LiAlH4, pro-
viding the corresponding pyrroloindoline without erosion of the enantiomeric purity.
The latter product was successively submitted to reductive cleavage of the N-N bond of
the hydrazine by treatment with SmI2, followed by N-methylation with formaldehyde
and NaBH(OAc)3, which led to the corresponding N-methylated product. The latter was
further converted into (þ)-esermethole through successive regioselective bromination
with NBS and CuI-catalyzed methoxylation of the resulting bromide.
In 2015, Lete et al. reported a novel access to the tetracyclic core of lycorane alka-
loids, such as (þ)-lycorine, based on an enantioselective intramolecular domino double
Heck reaction of N-benzyl-2,3-dialkenylpyrroles.36 As shown in Scheme 6, this process
was promoted by a chiral palladium catalyst generated in situ from Pd(OAc)2 and (R)-
BINAP as chiral ligand in the presence of 1,2,2,6,6-pentamethylpiperidine (PMP) as
base, providing the corresponding chiral pyrrolophenanthridines in moderate to good
yields (38-68%) and low to moderate enantioselectivities (7-72% ee).
Scheme 3
2. Wacker-Initiated Domino Reactions as Key Steps
Another important process based on palladium catalysis is the Wacker reaction.37,38 In
2005, Tietze et al. showed that it was possible to combine this process with a Heck reaction
in an enantioselective domino Wacker/Heck reaction.39 Later in 2006, this novel method-
ology was applied by these authors as key step in a novel total synthesis of vitamin E.40 As
depicted in Scheme 7, this key reaction consisted in the enantioselective palladium-cata-
lyzed domino Wacker/Heck reaction of a benzyl-protected phenol with methyl vinyl ketone
performed at room temperature in dichloromethane as solvent. It was promoted by a chiral
palladium catalyst generated in situ from Pd(TFA)2 and (S,S)-Bn-BOXAX as chiral ligand
in the presence of p-benzoquinone as reoxidant, leading to the corresponding chiral chro-
man in good yield (84%) and excellent enantioselectivity (97% ee), as shown in Scheme 7.
Scheme 4
This product was further converted into vitamin E through six supplementary steps, begin-
ning with its hydrogenation on PtO2. Then, the boron enolate of the resulting compound
was generated by treatment with diisopropylethylamine (DIPEA) as base and c-Hex2BCl,
and then submitted to an aldol reaction with a chiral aldehyde to give an a,b-unsaturated
ketone after treatment with p-toluenesulfonic acid. The latter was subsequently submitted to
Scheme 5
the addition of methyllithium to its carbonyl moiety to give the corresponding tertiary alco-
hol, which was converted into the corresponding diene over two steps by means of an elim-
ination catalyzed by p-toluenesulfonic acid. Finally, this diene was hydrogenated over Pd/C
with simultaneous deprotection of the benzylated phenolic hydroxyl group to give
vitamin E.
In 2007, Tietze et al. reported another type of enantioselective palladium-catalyzed
domino reaction initiated by a Wacker reaction, namely a three-component domino
Wacker/carbonylation reaction.41 The process occurred between unsaturated phenols,
alcohols and carbon dioxide to give the corresponding chiral chromans/benzodioxins
with both high yields and enantioselectivities of up to 99% and 99% ee, respectively.
The reaction was catalyzed by a palladium complex prepared in situ from Pd(TFA)2
and (S,S)-Bn-BOXAX as chiral ligand in the presence of p-benzoquinone as reoxidant
under carbon dioxide atmosphere at ambient pressure. In 2008, the utility of this meth-
odology was demonstrated by the same authors in a total synthesis of the natural
Scheme 6
product 4-dehydroxydiversonol.42 As shown in Scheme 8, the key step of this synthesis
was the asymmetric domino Wacker/carbonylation reaction of an alkenyl phenol with
methanol and carbon dioxide to give at room temperature the corresponding chiral ester
in high yield (80%) and excellent enantioselectivity (96% ee). The latter was further
converted into 4-dehydroxydiversonol through eight subsequent steps. The two first
steps involved a reduction by treatment with diisobutylaluminum hydride (DIBAL-H)
followed by a WittigHorner reaction of the thus-formed aldehyde with trimethyl
phosphonoacetate, providing the corresponding a,b-unsaturated ester. The latter was
submitted to the hydrogenation of its double bond on Pd/C followed by the oxidation of
the chroman moiety by treatment with t-BuOOH to give the corresponding chromanone.
Then, the intramolecular acylation at the a-position of the keto functionality by the ester
Scheme 7
moiety of this chromanone performed in the presence of TiCl4 and TEA led to the cor-
responding tetrahydroxanthone. This compound was then oxidized by treatment with
dimethyl dioxirane (DMDO) to afford the corresponding trans-a-hydroxy diketone as a
single diastereomer. Finally, the reduction of the latter with NaBH4 gave exclusively a
trans-diol which was further deprotected by treatment with BBr3 to afford the final 4-
dehydroxydiversonol (Scheme 8).
In 2016, the same methodology was also applied by these authors to develop a for-
mal total synthesis of the natural and biologically active pentacyclic chroman (-)-sicca-
nin.43 As shown in Scheme 9, the key step of this synthesis was the treatment of the
same alkenyl phenol by a chiral palladium catalyst generated in situ from Pd(TFA)2
and enantiomeric ligand (R,R)-Bn-BOXAX under the same reaction conditions, afford-
ing the corresponding chiral chroman in good yield (71%) and high enantioselectivity
(93% ee). This key intermediate was converted into (-)-siccanin through eight steps,
beginning with its reduction with diisobutylaluminum hydride to give the corresponding
Scheme 8
aldehyde. The latter was submitted to an aldol reaction with a trimethylsilyl enol ether
in the presence of BF3(Et2O) to provide the corresponding aldol product. Then, this
compound was treated with Burgess reagent to give the related a,b-unsaturated ketone
as a major diastereomer which was further separated and hydrogenated on Pd/C into the
corresponding cyclohexanone. The latter was then submitted to a Peterson olefination
Scheme 9
to provide the corresponding methylene cyclohexane. A subsequent Sharpless dihydrox-
ylation led to the corresponding diol. This compound constituted a late intermediate in
the synthesis of (-)-siccanin earlier reported by Trost et al., in 2003.44
A possible mechanism for the key asymmetric domino Wacker/carbonylation reac-
tion of the precedent synthesis is depicted in Scheme 10. It involves the addition of a
palladium complex on the Si-face of the external double bond to give an intermediate
palladium derivative. The latter was then submitted to a CO insertion followed by
methoxylation to afford the final domino product.
3. Other Domino Reactions as Key Steps
In 2009, Trost et al. developed a total synthesis of the naturally occurring anticancer
agent (þ)-agelastatin A which was based on an enantioselective palladium-catalyzed
domino double allylic alkylation reaction.45 As illustrated in Scheme 11, the domino
reaction of a bis-allylic carbonate with a diamine led to a key intermediate piperazinone
in high yield (82%) and excellent enantioselectivity (>97% ee) when catalyzed by a
chiral palladium complex in situ generated from [Pd2(dba)3](CHCl3) and Trost ligand
(R,R)-LST in the presence of acetic acid. This key piperazinone was further converted
into (þ)-agelastatin A through four further steps, the first one of which was the copper-
catalyzed aziridination of the domino product into the corresponding tetracyclic aziri-
dine. The treatment of the latter with In(OTf)3 afforded a tricyclic a-amino ketone.
Then, the required installation of the D-ring urea of (þ)-agelastatin A was achieved by
treating this a-amino ketone with methyl isocyanate in the presence of Cs2CO3 to give
the corresponding tetracyclic compound. Finally, removing the N-Ts and N-OMe groups
was achieved through SmI2-mediated radical reduction, leading to (þ)-agelastatin A.
II. Syntheses Based on Copper-Catalyzed Domino Reactions
1. Michael-Initiated Domino Reactions as Key Steps
Related to the growing interest in green chemistry, domino reactions promoted by cop-
per catalysts represent a challenge in organic chemistry. Among them, a number of
asymmetric domino reactions are initiated by a Michael addition. For example, an enan-
tioselective three-component copper-catalyzed domino Michael/aldol reaction
Scheme 10
constituted the key step in a total synthesis of ()-prostaglandin E1 methyl ester
reported by Feringa et al., in 2001.46 As shown in Scheme 12, this key reaction
occurred between a dioxane acetal, a dialkylzinc reagent and an aldehyde in the pres-
ence of a copper catalyst in situ generated from Cu(OTf)2 and a chiral phosphoramidite
as ligand, giving the corresponding Michael/aldol domino product in 60% yield as an
inseparable 83:17 mixture of diastereomers. The reduction of the ketone moiety in this
product proceeded stereoselectively using Zn(BH4)2 to give the corresponding diol as a
major diastereomer with 94% ee and 63% yield. In the next step, the silyl group was
removed by treatment with TBAF and then the resulting compound was acetylated with
Ac2O in pyridine to give the corresponding diacetate. Then, the latter was submitted to
a 1,3-allylic transposition in the presence of Pd(MeCN)2Cl2 to give the corresponding
allylic acetate. After deacetylation with K2CO3 in methanol, a chiral 1,5-diol was
Scheme 11
obtained. The final step of the synthesis dealt with the deprotection of the ketone func-
tionality of this compound by using (NH4)2Ce(NO3)6, leading to ()-prostaglandin E1
methyl ester, as detailed in Scheme 12.
Scheme 12
In 2010, the same authors reported another enantioselective copper-catalyzed dom-
ino reaction initiated by a Michael addition which constituted the key step of formal
syntheses of natural products cascarillic acid and grenadamide.47 This asymmetric dom-
ino Michael/intramolecular alkylation reaction occurred between Grignard reagents and
4-chloro-a,b-unsaturated esters/thioesters/ketones in the presence of a combination of
CuI and (R)-Tol-BINAP as chiral ligand, as shown in Scheme 13. It afforded the corre-
sponding chiral trans-1-alkyl-2-substituted cyclopropane esters/thioesters/ketones in
moderate to excellent yields (56->95%) and high enantioselectivities (84-98% ee).
These various products constituted key intermediates for formal syntheses of cascarillic
acid and grenadamide previously reported by Cheeseman and Bull.48
In 2012, Riant et al. described the preparation of a key intermediate for a total syn-
thesis of the natural diterpene marrubiin exhibiting antinociceptive and expectorant
effects. This was based on an enantioselective copper-catalyzed domino reductive
Michael/aldol cyclization reaction.49 As shown in Scheme 14, this domino process
began with the reductive Michael reaction of a diketoester with phenylsilane performed
in the presence of a chiral copper catalyst derived from a Taniaphos ligand, leading to
Scheme 13
the corresponding bicyclic chiral domino product as a single cis-diastereomer in good
yield (80%) and excellent enantioselectivity (95% ee). This product was further submit-
ted to dehydration by successive treatments with TFA, TMSCH2N2 and SOCl2 to give
the corresponding non-conjugated cyclohexenone. The latter was then methylated in the
presence of LDA and methyl iodide to provide the corresponding bicyclic ester after
required protection of the ketone group as dioxolane. This compound constituted a cru-
cial intermediate in the synthesis of marrubiin previously reported.50
Scheme 14
2. Other Domino Reactions as Key Steps
In 2011, Hajra and Bar developed an enantioselective copper-catalyzed domino azir-
idination/FriedelCrafts cyclization reaction as key step in a total synthesis of the
dopamine D1 agonist A-86929.51 As depicted in Scheme 15, the reaction of a func-
tionalized styrene with PhINNs was promoted by a copper catalyst in situ generated
from Cu(OTf)2 and a chiral bisoxazoline ligand, leading to the corresponding chiral
bicyclic domino product in good yield (82%), complete trans-diastereoselectivity
(>98% de) and excellent enantioselectivity (95% ee). This product was converted
into A-86929 through four additional steps, beginning with the reaction of its
sodium salt generated by treatment with NaH with MOMCl, providing the corre-
sponding methoxy methyl ether. The PictetSpengler-type cyclization of this com-
pound using TMSOTf afforded a tetracyclic product which was subsequently
deprotected by treatment with p-methoxythiophenol and K2CO3 to give the corre-
sponding secondary amine. Finally, the demethylation of the latter performed with
BBr3 accomplished the synthesis of A-86929.
Earlier in 2006, Knochel et al. had developed a synthesis of the highly toxic
alkaloid (S)-(þ)-coniine, which is known to induce curare-type paralysis.52 The key
step of this synthesis was an asymmetric copper-catalyzed three-component reac-
tion among butyraldehyde, trimethylsilylacetylene and dibenzylamine catalyzed by
a chiral complex derived from CuBr and (R)-QUINAP as ligand (Scheme 16). This
domino process afforded the corresponding chiral propargylamine in both excellent
yield (90%) and enantioselectivity (90% ee). This product was further converted
into (S)-(þ)-coniine through six steps. First, the domino compound was desilylated
by treatment with TBAF to give the corresponding alkyne which was subsequently
deprotonated with n-BuLi and then alkylated with ethylene oxide. After silylation
of the resulting alcohol with TIPSCl, the corresponding TIPS ether was obtained.
Then, the latter was successively submitted to hydrogenation on Pd/C, desilylation
with Bu4NF and intramolecular Mitsunobu reaction to finally afford
(S)-(þ)-coniine.
In 2013, Watanabe and Shibasaki reported a formal total synthesis of antiviral osel-
tamivir phosphate (Tamiflu) which employed as crucial step another enantioselective
copper-catalyzed three-component reaction.53 As shown in Scheme 17, the reaction
occurred among bis(2-phenylallyl)amine, ethyl propiolate and an aldehyde and was pro-
moted by a chiral copper catalyst in situ generated from CuBr and a (R,R)-O-PINAP
ligand. It afforded the corresponding chiral domino product in good yield (84%) and
moderate enantioselectivity (76% ee). This compound was further converted through a
seven-step sequence into Corey’s intermediate for the total synthesis of oseltamivir
phosphate. The first step of the sequence dealt with the poisoned palladium-catalyzed
hydrogenation of the domino product into the corresponding triene followed by a
Dieckmann condensation in the presence of LiHMDS to give the corresponding six-
membered compound. The ketone functionality of the latter was further reduced with
NaBH4 to give the corresponding alcohol. Then, the two 2-phenylallyl groups of this
alcohol were removed by allylic substitution in the presence of Pd(PPh3)4 and N,N-
dimethylbarbituric acid as nucleophile, which was followed by introduction of the Boc
group to give the corresponding N-Boc-protected amine. Finally, mesylation of the lat-
ter followed by subsequent b-elimination afforded Corey’s intermediate for the total
synthesis of oseltamivir phosphate.
Scheme 15
III. Syntheses Based on Rhodium-Catalyzed Domino Reactions
Domino carbonyl ylide formation/1,3-dipolar cycloaddition reactions allow a direct
access to many complex heterocycles.54–56 In 2010, Hashimoto et al. developed an
asymmetric version of this methodology as a significant step in a total synthesis of a
natural product.57 The key intermediate of this synthesis was formed through the enan-
tioselective rhodium-catalyzed domino reaction of the formyl-derived carbonyl ylide
generated from a diazo compound with 4-hydroxy-3-methoxyphenylacetylene. When
the reaction was catalyzed by Rh2(S-TCPTTL)4, this cycloadduct was obtained in good
yield (73%) and excellent enantioselectivity (95% ee), as illustrated in Scheme 18. This
product was further converted into the expected natural product having blood circula-
tion properties through eight steps. In the first one, the phenolic ester group of the dom-
ino product was protected as tert-butyldiphenylsilyl ether. Then, treatment of this ether
by NaHMDS followed by addition of PhNTf2 and subsequent palladium-catalyzed
reduction of the resulting enol triflate led to the corresponding 1,4-diene. Then, the
reduction of the latter with LiAlH4 and subsequent silylation provided the correspond-
ing diether which was further submitted to allylic oxidation with SeO2 to afford the cor-
responding allylic alcohol as a single diastereomer. The latter was oxidized with MnO2
to give the corresponding a,b-unsaturated ketone which was finally converted into the
Scheme 16
desired natural product through removing the two TBDPS protecting groups by treat-
ment with TBAF.
The same authors also described the synthesis of another natural and biologically
active product, descurainin, on the basis of the same domino reaction albeit catalyzed
with the enantiomeric catalyst Rh2(R-TCPTTL)4.
58 As shown in Scheme 19, by using
this catalyst the corresponding enantiomeric cycloadduct was obtained in good yield
(77%) and excellent enantioselectivity (95% ee). A sequence of twelve further
Scheme 17
Scheme 18
Scheme 19
supplementary steps allowed expected descurainin to be achieved from this domino
product. In the first step, hydrogenation of the latter on Pd/C led to the corresponding
saturated bicyclic compound as a single diastereomer, which was then treated with
(KSO3)2NO in the presence of KH2PO4 to give the corresponding o-quinone. The latter
was directly converted into a catechol by treatment with Na2S2O4. Subsequent treatment
of this catechol with methyl iodide and K2CO3 led to the corresponding per-methylated
compound. Then, treatment of the latter with NaHMDS followed by addition of
PhNTf2 and subsequent palladium-catalyzed reduction of the resulting enol triflate gave
the corresponding alkene. The further reduction of the latter with LiAlH4 led to the cor-
responding alcohol. Subsequent treatment of this alcohol with NbCl5 allowed regiose-
lective demethylation to give the corresponding phenol as a sole product. Then,
protection of the two hydroxyl groups of this phenol with TBDPSCl provided the corre-
sponding diether which was further submitted to an allylic oxidation with SeO2 fol-
lowed by an oxidation with MnO2 to give the corresponding a,b-unsaturated ketone.
Finally, the removal of the two TBDPS protecting groups of this enone with TBAF
completed the total synthesis of descurainin (Scheme 19).
IV. Syntheses Based on Aluminum-Catalyzed Domino Reactions
In 1996, Shibasaki et al. reported the first catalytic asymmetric domino Michael/aldol
reaction.59 Promoted by a heterobimetallic chiral complex, such as AlLibis[(R)-
binaphthoxide], this three-component reaction between cyclopentenones, aldehydes and
methyl-substituted dibenzyl malonates led to the corresponding multifunctionalized
chiral cyclopentanones with enantioselectivities of up to 91% ee. In 1998, this method-
ology was applied by the same authors to develop a total synthesis of 11-deoxy-
PGF1a.
60 As shown in Scheme 20, the three-component domino Michael/aldol reaction
of cyclopentenone, an aldehyde and dibenzyl methylmalonate performed in the presence
of enantiomeric AlLibis[(S)-binaphthoxide] provided the corresponding chiral product
in 84% yield and up to 88% de. This domino product was further converted through
fourteen steps into 11-deoxy-PGF1a. The sequence began with the conversion of the
domino product into the corresponding a,b-unsaturated ketone through successive
mesylation and elimination. Then, hydrosilylation of this ketone catalyzed by chloro-
tris(triphenylphosphine)rhodium gave the corresponding trans-ketone which was subse-
quently reduced with L-Selectride into the corresponding alcohol as a single product.
Then, this alcohol was protected with tert-butyldimethylsilyl trifluoromethanesulfonate
to give the corresponding TBS ether. The latter was further transformed into the corre-
sponding methyl ketone through successive treatments with hydrogen on Pd/C,
Pb(OAc)4 and K2CO3. Then, the aldol reaction of this methyl ketone with hexanal fol-
lowed by elimination provided the corresponding a,b-unsaturated ketone. The subse-
quent treatment of this ketone with La-(S)-3-(hydroxymethyl)binaphthol complex led to
the corresponding epoxide which was further subjected to Wharton reaction conditions
to give the corresponding allylic alcohol. Finally, the deprotection of this alcohol by
treatment with HF led to 11-deoxy-PGF1a.
Another asymmetric aluminum-catalyzed three-component reaction was developed
by Shibasaki et al., involving a pyridine derivative, TMSCN and a carbonyl chloride as
substrates.61 Promoted by a chiral aluminum catalyst in situ generated from Et2AlCl
and a BINOL-derived sulfoxide chiral ligand, it afforded the corresponding chiral cyan-
ide in quantitative yield (98%) and high enantioselectivity (91% ee), as shown in
Scheme 20
Scheme 21. The synthetic utility of this methodology was demonstrated by its applica-
tion to the formal synthesis of the dopamine D4 receptor-selective antagonist CP-
293,019.62 Indeed, the domino product was converted through nine steps into an
important primary alcohol intermediate in the synthesis of CP-293,019. The synthetic
route began with a two-step hydrogenation of the domino product followed by a protec-
tion/deprotection sequence, leading to the corresponding tetrahydropyridine. Reduction
of the latter with NaBH3CN via an iminium cation proceeded in a 4:1 ratio, and the iso-
lated major diastereomer was annulated to give a bicyclic diamine. Then, the known
key primary alcohol intermediate63 was achieved from this bicyclic diamine in three
supplementary steps.
V. Syntheses Based on Domino Reactions Catalyzed by Other Metals
In 1999, Ihara and Nemoto reported a total synthesis of the natural product (þ)-equile-
nin based on an asymmetric manganese-catalyzed domino epoxidation/ring-expansion
Scheme 21
reaction of a cyclopropylidene.64,65 This domino process was catalyzed by a chiral pre-
formed salen manganese complex in the presence of sodium hypochlorite as oxidant,
leading through successive epoxidation and ring-expansion to the corresponding chiral
cyclobutanone in moderate yield (55%) and good enantioselectivity (78% ee), as
Scheme 22
illustrated in Scheme 22. The latter was converted into the steroid (þ)-equilenin through
five supplementary steps. This sequence began with the stereoselective conversion of
the domino product into the corresponding isopropenylcyclobutanol by Grignard reac-
tion with isopropenylmagnesium bromide in the presence of cerium trichloride. Then, a
palladium-mediated cascade ring expansion/insertion reaction occurred to give the cor-
responding 11-methylene steroid as a diastereomeric mixture which was subsequently
treated with osmium tetroxide and sodium periodate to give the corresponding diketone.
The latter was further submitted to hydrogenolysis on Pt/C in the presence of PdCl2 to
afford equilenin methyl ether. A subsequent deprotection performed in the presence of
BBr3 led finally to (þ)-equilenin.
With the aim of synthesizing precursors to GABA analogues, Sudalai and Paraskar
developed in 2006 a novel enantioselective cobalt-catalyzed domino reductive cycliza-
tion reaction of substituted c-azido-a,b-unsaturated esters to afford the corresponding
c-lactams with enantioselectivities of up to 98% ee.66 The process was promoted by a
cobalt catalyst in situ generated from CoCl2 and a chiral oxazoline ligand in the
Scheme 23
presence of NaBH4 as reducing agent. This methodology was applied to the syntheses
of (R)-rolipram and (R)-baclofen which are respectively a potent inhibitor of the cardiac
cyclic AMP phosphodiesterase and a GABA agonist. As shown in Scheme 23 (first
equation), (R)-rolipram was directly obtained with both high yield (92%) and enantiose-
lectivity (92% ee) from the domino reaction of a c-azido olefinic ester prepared in six
steps from 2-methoxyphenol. The synthesis of (R)-baclofen was achieved through
hydrolysis with 6M HCl of another domino product (Scheme 23, second equation) also
obtained with both high yield (82%) and enantioselectivity (89% ee).
In 2007, Kobayashi et al. reported the total synthesis of the natural cytotoxic C2-
symmetric cyclic decadepsipeptide onchidin.67 The key step of this synthesis was an
enantioselective Mannich-type reaction between 2-amino-m-cresol, 5-hexynal and a
ketene silyl acetal derived from phenyl propionate which was promoted by a chiral zir-
conium catalyst derived from a fluorinated (S)-BINOL as ligand. As shown in Scheme
24, this three-component process led to the formation of the corresponding chiral
Scheme 24
Scheme 25
Mannich anti-product in both good yield (85%) and diastereoselectivity (82% de) com-
bined with excellent enantioselectivity (96% ee). Then, this domino product was con-
verted into the corresponding N-Boc-protected dipeptide in four steps. The latter was
further coupled with the hydrochloride salt of a tridepsipeptide to give the correspond-
ing pentadepsipeptide. This compound was coupled with another pentadepsipeptide to
give the corresponding linear decadepsipeptide. Cleavage of the TMS group followed
by N-Boc deprotection and final macrocyclization afforded onchidin.
In 2016, Dixon et al. reported a novel total synthesis of the antibiotic (-)-chlorampheni-
col based on an enantioselective silver-catalyzed domino aldol/cyclization reaction.68 In this
key step, p-nitrobenzaldehyde reacted with an isocyano acetate to give the corresponding
trans-oxazoline in moderate yield (72%) and both good diastereoselectivity (82% de) and
enantioselectivity (89% ee), as illustrated in Scheme 25. This process was promoted at
room temperature with a chiral silver catalyst in situ generated from Ag2O and a cinchona
alkaloid as ligand. The formed chiral domino product was further converted into (-)-chlor-
amphenicol through four supplementary steps, which are detailed in Scheme 25. The ring-
opening of the domino product using thionyl chloride provided the corresponding amino
alcohol which was further acetylated with dichloroacetyl chloride to give the corresponding
dichloroacetamide. Finally, the chemoselective reduction of the ester group in this com-
pound with sodium borohydride delivered (-)-chloramphenicol.
Conclusion
This review collects total asymmetric syntheses of natural and/or biologically important
products using enantioselective metal-catalyzed domino reactions as key steps. It shows
that these economic one-pot processes have already allowed many important complex
molecules to be achieved from simple starting materials. The increasing diversity of
these fascinating reactions well reflects that of the metals employed to promote them.
For example, various types of chiral palladium catalysts have been applied to promote
asymmetric Heck-initiated domino reactions with enantioselectivities of up to 94% ee
which were employed as key steps in total syntheses of different natural and/or bio-
active products, such as (-)-xestoquinone, (þ)-halenaquinone, (-)-physostigmine and
(þ)-esermethole. Other chiral palladium complexes were also used to promote asym-
metric Wacker-initiated domino reactions achieved with up to 96% ee used as key steps
in total syntheses of vitamin E, 4-dehydroxydiversonol and (-)-siccanin. Moreover,
another type of palladium-catalyzed domino process, including a domino double allylic
alkylation reaction, was employed in the total synthesis of (þ)-agelastatin, providing
enantioselectivities of up to >97% ee. Related to the growing interest in green chemis-
try, domino reactions promoted by green copper catalysts represent a challenge in
organic chemistry. In this context, many types of asymmetric domino reactions cata-
lyzed by a variety of chiral copper complexes have been applied as key steps in total
syntheses. For example, copper-catalyzed Michael-initiated domino processes achieved
with enantioselectivities of 94-98% ee have allowed the synthesis of important prod-
ucts, such as PGE1 methyl ester, grenadamide and marrubiin. Moreover, total syntheses
of A-86929, (S)-(þ)-coniine and Tamiflu have been based on other enantioselective
domino reactions including three-component ones with enantioselectivities of up to
95% ee. Along with palladium and copper chiral complexes, rhodium chiral catalysts
have been applied in different types of domino reactions with 88-91% ee, constituting
the key steps in the total syntheses of 11-deoxy-PG1a and CP-293,019. Moreover, the
use of chiral complexes derived from other metals, such as manganese, cobalt, zirco-
nium and silver, also provided excellent enantioselectivities of up to 96% ee in different
types of domino reactions in the total syntheses of (þ)-equilenin, (R)-baclofen, onchidin
and (-)-chloramphenicol. Undoubtedly, many other enantioselective metal-promoted
asymmetric domino reactions will be discovered in the near future and further applied
as key economic steps in total synthesis.
Abbreviations
BINAP 2,2’-bis(diphenylphosphino)-1,1’-binaphthyl
BINOL 1,1'-bi-2-naphthol
Bn benzyl
Boc tert-butoxycarbonyl
BOXAX 2,2’-bis(oxazolyl)-1,1’-binaphthyl
Bt benzotriazol
CAN ceric ammonium nitrate
dba (E,E)-dibenzylideneacetone
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene
DDQ 2,3-dichloro-5,6-dicyano-p-benzoquinone
de diastereomeric excess
DEAD diethyl azodicarboxylate
DIBAL (DIBAL-H) diisobutylaluminium hydride
DIFLUORPHOS 5,5’-bis(diphenylphosphino)-2,2,2’,2’-tetrafluoro-4,4’-bi-1,3-
benzodioxole
DIPEA diisopropylethylamine
DMAP 4-(dimethylamino)pyridine
DMDO dimethyl dioxirane
DMF N,N-dimethylformamide
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride
ee enantiomeric excess
GABA c-aminobutyric acid
Hex hexyl
HMDS hexamethyldisilazide
LDA lithium diisopropylamide
MOM methoxymethyl
NBS N-bromosuccinimide
NMI N-methylimidazole
Ms mesyl
M.S. molecular sieves
NBS N-bromosuccinimide
NMI N-methylimidazole
Ns nosyl (4-nitrobenzene sulfonyl)
Phox phosphinooxazoline
PINAP 4-[2-(diphenylphosphino)-1-naphthalenyl]-N-[1-phenylethyl]-1-
phthalazinamine
PMP 1,2,2,6,6-pentamethylpiperidine
QUINAP 1-(2-diphenylphosphino-1-naphthyl)isoquinoline
r.t. room temperature
SES b-trimethylsilylethanesulfonyl
Taniaphos [2-diphenylphosphinoferrocenyl](N,N-dimethylamino)(2-
diphenylphosphinophenyl)methane
TBAF tetrabutylammonium fluoride
TBDPS tert-butyldiphenylsilyl
TBHP tert-butylhydroperoxide
TBS tert-butyldimethylsilyl
TCPTTL N-tetrachlorophthaloyl-tert-leucinate
TEA triethylamine
Tf trifluoromethanesulfonyl
TFA trifluoroacetic acid
THF tetrahydrofuran
TIPS triisopropylsilyl
TMG 1,1,3,3-tetramethylguanidine
TMS trimethylsilyl
Tol tolyl
Ts 4-toluenesulfonyl (tosyl)
Val valine
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